Euro
-
Company said the financing will help it take advantage of opportunities in the development of metabolic drugs
-
The Aussie bank will visit four European cities next week during the deal's roadshow
-
Sovereign envisions regular issuance as it brings second benchmark in recent years
-
The euro market has struck a delicate balance when it comes to pricing and sizing
-
Less exuberance in bookbuilding and secondary widening follows primary market onslaught
-
◆ Finnvera joins dollar party in primary ◆ Attractive levels and lack of supply boost demand ◆ Another German issuer brings 10 year euro paper
-
◆ Small benchmarks hit screens ◆ Demand solid but muted ◆ Market prepared for cooling off period after rampant few weeks
-
◆ PBB opts for four year deal ◆ Marginal drops as German issuer tightens spread ◆ Investors appreciate the room for performance
-
◆ Fair value debated ◆ Some question RV attractiveness to global investors ◆ Dollars main funding market ‘for now’
-
◆ New senior FIG deals print with mid-single digit concessions... ◆... though Belfius offers more for its largest non-preferred funding since 2020 ◆ M&A target Monte dei Paschi prints year's first deal
-
◆ First euro and social combo since 2022 ◆ Deal follows another MDB five year ◆ Market capable of absorbing similar deals
-
◆ Single digit premium paid ◆ Slim pick up offered over Canadian peers ◆ Canadian covered paper lower in euros this year to date